C15ORF44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.754400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.019000E-01
Normal-vs-Stage2
6.868200E-01
Normal-vs-Stage3
8.156200E-02
Normal-vs-Stage4
7.373400E-01
Stage1-vs-Stage2
1.873630E-01
Stage1-vs-Stage3
2.920300E-02
Stage1-vs-Stage4
3.894800E-01
Stage2-vs-Stage3
7.769600E-02
Stage2-vs-Stage4
9.607600E-01
Stage3-vs-Stage4
1.634010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.087600E-01
Normal-vs-AfricanAmerican
6.756000E-01
Normal-vs-Asian
4.154800E-01
Caucasian-vs-AfricanAmerican
9.814600E-01
Caucasian-vs-Asian
2.457200E-01
AfricanAmerican-vs-Asian
4.758000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.914800E-01
Normal-vs-Female
7.863800E-01
Male-vs-Female
2.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.096400E-01
Normal-vs-Age(41-60Yrs)
7.953800E-01
Normal-vs-Age(61-80Yrs)
5.736600E-01
Normal-vs-Age(81-100Yrs)
9.225600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.103200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.180000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.533400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.161200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.725000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.609000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.123200E-01
Normal-vs-Daily Drinker
5.909400E-01
Normal-vs-Weekly Drinker
5.495200E-01
Normal-vs-Occasional Drinker
6.590200E-01
Normal-vs-Social Drinker
4.411200E-01
Non Drinker-vs-Daily Drinker
8.888800E-01
Non Drinker-vs-Weekly Drinker
8.150600E-01
Non Drinker-vs-Occasional Drinker
5.495200E-01
Non Drinker-vs-Social Drinker
9.382800E-01
Daily Drinker-vs-Weekly Drinker
7.552800E-01
Daily Drinker-vs-Occasional Drinker
6.811400E-01
Daily Drinker-vs-Social Drinker
8.477400E-01
Weekly Drinker-vs-Occasional Drinker
5.043400E-01
Weekly Drinker-vs-Social Drinker
8.823000E-01
Occasional Drinker-vs-Social Drinker
5.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.357600E-01
Normal-vs-Grade 2
9.048400E-01
Normal-vs-Grade 3
8.770400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.577200E-01
Grade 1-vs-Grade 3
3.081400E-01
Grade 1-vs-Grade 4
9.357600E-01
Grade 2-vs-Grade 3
5.161400E-01
Grade 2-vs-Grade 4
9.048400E-01
Grade 3-vs-Grade 4
8.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.726200E-01
Normal-vs-NonDiabetic
6.849000E-01
Diabetic-vs-NonDiabetic
1.043780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.853400E-01
Normal-vs-NoPancreatitis
6.119600E-01
Pancreatitis-vs-NoPancreatitis
3.462000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.056400E-01
Normal-vs-N1
7.311200E-01
N0-vs-N1
6.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.748800E-01
Normal-vs-TP53-NonMutant
9.068000E-01
TP53-Mutant-vs-TP53-NonMutant
7.706100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
